GB9207517D0 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
GB9207517D0
GB9207517D0 GB929207517A GB9207517A GB9207517D0 GB 9207517 D0 GB9207517 D0 GB 9207517D0 GB 929207517 A GB929207517 A GB 929207517A GB 9207517 A GB9207517 A GB 9207517A GB 9207517 D0 GB9207517 D0 GB 9207517D0
Authority
GB
United Kingdom
Prior art keywords
heterocyclic compounds
heterocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929207517A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB929207517A priority Critical patent/GB9207517D0/en
Publication of GB9207517D0 publication Critical patent/GB9207517D0/en
Priority to HU9402850A priority patent/HUT68937A/en
Priority to CZ942429A priority patent/CZ242994A3/en
Priority to ZA932458A priority patent/ZA932458B/en
Priority to EP93907992A priority patent/EP0634996A1/en
Priority to CA002133744A priority patent/CA2133744A1/en
Priority to SK1209-94A priority patent/SK120994A3/en
Priority to IL105322A priority patent/IL105322A0/en
Priority to MX9301962A priority patent/MX9301962A/en
Priority to JP5517264A priority patent/JPH07505388A/en
Priority to PCT/GB1993/000708 priority patent/WO1993020044A1/en
Priority to AU38992/93A priority patent/AU3899293A/en
Priority to CN93105698A priority patent/CN1083048A/en
Priority to NO943737A priority patent/NO943737L/en
Priority to KR1019940703520A priority patent/KR950700874A/en
Priority to FI944657A priority patent/FI944657A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205Radicals derived from carbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/32Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C271/34Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB929207517A 1992-04-06 1992-04-06 Heterocyclic compounds Pending GB9207517D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB929207517A GB9207517D0 (en) 1992-04-06 1992-04-06 Heterocyclic compounds
CN93105698A CN1083048A (en) 1992-04-06 1993-04-05 Heterogeneous ring compound
SK1209-94A SK120994A3 (en) 1992-04-06 1993-04-05 1,4-naphthoquinone derivatives with anti-protozoal and anti- -parasitic activity
MX9301962A MX9301962A (en) 1992-04-06 1993-04-05 HETERO CYCLIC COMPOUNDS.
ZA932458A ZA932458B (en) 1992-04-06 1993-04-05 Naphtoquinones and their use.
EP93907992A EP0634996A1 (en) 1992-04-06 1993-04-05 1,4 naphthoquinone derivtives with anti-protozoal and anti-parasitic activity
CA002133744A CA2133744A1 (en) 1992-04-06 1993-04-05 1,4 naphthoquinone derivatives with anti-protozoal and anti-parasitic activity
HU9402850A HUT68937A (en) 1992-04-06 1993-04-05 1,4-naphthoquinone derivs with anta-protozoal and anti-parasitic activity, pharmaceutical compns. contg. them and process for preparation the sald compd.s
IL105322A IL105322A0 (en) 1992-04-06 1993-04-05 Naphthoquinone derivatives,their preparation and pharmaceutical compositions containing them
CZ942429A CZ242994A3 (en) 1992-04-06 1993-04-05 1,4-naphthoquinone derivatives exhibiting anti-protozoic and anti-parasitic activity
JP5517264A JPH07505388A (en) 1992-04-06 1993-04-05 1,4-naphthoquinone derivatives with antiprotozoal and antiparasitic activity
PCT/GB1993/000708 WO1993020044A1 (en) 1992-04-06 1993-04-05 1,4 naphthoquinone derivtives with anti-protozoal and anti-parasitic activity
AU38992/93A AU3899293A (en) 1992-04-06 1993-04-05 1,4 naphthoquinone derivtives with anti-protozoal and anti-parasitic activity
FI944657A FI944657A (en) 1992-04-06 1994-10-05 1,4-naphthoquinone derivatives with herbicidal and parasitic antagonistic activity
NO943737A NO943737L (en) 1992-04-06 1994-10-05 1,4-naphthoquinone derivatives with anti-protozoan and anti-parasitic activity
KR1019940703520A KR950700874A (en) 1992-04-06 1994-10-05 1,4-naphthoquinone derivatives with anti-protozoan and anti-parasitic activity (1,4-NAPHTHOQUINONE DERIVTIVES WITH WITH ANTI PROTOZAL AND ANTI PARASITIC ACTIVITY)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929207517A GB9207517D0 (en) 1992-04-06 1992-04-06 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB9207517D0 true GB9207517D0 (en) 1992-05-20

Family

ID=10713546

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929207517A Pending GB9207517D0 (en) 1992-04-06 1992-04-06 Heterocyclic compounds

Country Status (16)

Country Link
EP (1) EP0634996A1 (en)
JP (1) JPH07505388A (en)
KR (1) KR950700874A (en)
CN (1) CN1083048A (en)
AU (1) AU3899293A (en)
CA (1) CA2133744A1 (en)
CZ (1) CZ242994A3 (en)
FI (1) FI944657A (en)
GB (1) GB9207517D0 (en)
HU (1) HUT68937A (en)
IL (1) IL105322A0 (en)
MX (1) MX9301962A (en)
NO (1) NO943737L (en)
SK (1) SK120994A3 (en)
WO (1) WO1993020044A1 (en)
ZA (1) ZA932458B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9169232B2 (en) * 2011-09-16 2015-10-27 Alkem Laboratories Limited 3-(5-methyl-2-oxo-l, 3-dioxol-4-yl) methyloxy-2-trans-[(4-chloro phenyl) cyclohexyl][1,4]naphthaquinone-atovaquone prodrug
JP2019523779A (en) 2016-06-20 2019-08-29 ザ スクリプス リサーチ インスティテュート Antimalarial composition and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
JP2804302B2 (en) * 1988-08-16 1998-09-24 ザ ウエルカム フアウンデーション リミテッド Therapeutic agent

Also Published As

Publication number Publication date
IL105322A0 (en) 1993-08-18
NO943737D0 (en) 1994-10-05
FI944657A (en) 1994-12-02
SK120994A3 (en) 1995-07-11
KR950700874A (en) 1995-02-20
CA2133744A1 (en) 1993-10-14
CN1083048A (en) 1994-03-02
JPH07505388A (en) 1995-06-15
HUT68937A (en) 1995-08-28
EP0634996A1 (en) 1995-01-25
HU9402850D0 (en) 1995-01-30
FI944657A0 (en) 1994-10-05
WO1993020044A1 (en) 1993-10-14
ZA932458B (en) 1994-10-05
CZ242994A3 (en) 1995-06-14
MX9301962A (en) 1993-11-01
NO943737L (en) 1994-11-29
AU3899293A (en) 1993-11-08

Similar Documents

Publication Publication Date Title
HU9402443D0 (en) Heterocyclic compounds
GB9208492D0 (en) Heterocyclic compounds
GB9304500D0 (en) Heterocyclic compounds
GB9318738D0 (en) Heterocyclic compounds
ZA939584B (en) Heterocyclic compounds
ZA935213B (en) Heterocyclic compounds
HU9300217D0 (en) Heterocyclic compounds
GB9219632D0 (en) Heterocyclic compounds
GB9317761D0 (en) Heterocyclic compounds
GB9319243D0 (en) Heterocyclic compounds
GB9223371D0 (en) Heterocyclic compounds
GB9218240D0 (en) Heterocyclic compounds
GB9207517D0 (en) Heterocyclic compounds
GB9212924D0 (en) Heterocyclic compounds
GB9208496D0 (en) Heterocyclic compounds
GB9219633D0 (en) Heterocyclic compounds
GB9218780D0 (en) Heterocyclic compounds
GB9217362D0 (en) Heterocyclic compounds
GB9216779D0 (en) Heterocyclic compounds
GB9215360D0 (en) Heterocyclic compounds
GB9201426D0 (en) Heterocyclic compounds
GB9208505D0 (en) Heterocyclic compounds
GB9203607D0 (en) Heterocyclic compounds
ZA932697B (en) Heterocyclic compounds
GB9208380D0 (en) Heterocyclic compounds